Japanese officials enter a Kobayashi Pharmaceutical factory to conduct an on-site inspection in Osaka City, on 30 March, 2024. Photo: AFP/ Mami Nagaoki
Previous
Company wins court ruling to continue development of Michigan factory serving EV industry
Next
US overdose deaths dropped in 2023, the first time since 2018